Physiological Regulation of Chronic Tinnitus
NeuroTin
1 other identifier
interventional
85
1 country
1
Brief Summary
The present project involves research on humans with the aim to characterize the reduction of chronic, continuous, non-pulsatile and debilitating tinnitus in humans by comparing neurofeedback (fMRI or EEG) to the current gold standard behavioral cognitive therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 14, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 6, 2022
CompletedFirst Submitted
Initial submission to the registry
February 10, 2023
CompletedFirst Posted
Study publicly available on registry
February 21, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2023
CompletedNovember 14, 2023
November 1, 2023
5.8 years
February 10, 2023
November 13, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Behavioral improvement of tinnitus as measured by the Tinnitus Handicap Inventory (THI)
To show that behavioral improvement of tinnitus after intensive neurofeedback training is equivalent or better than improvement obtained after attending group cognitive behavioral therapy, as measured by Tinnitus Handicap Inventory (THI) scores reported before experiment and at late post-assessment (significant difference, p-value \< 0.05). THI ranges from low scores (grade 1 - slight or no handicap), to highest scores (grade 5 - catastrophic handicap).
8 months
Secondary Outcomes (6)
Audiological measures
8 months
Training effect
8 months
Other factors
8 months
Correlation with BOLD signal
8 months
Correlation with alpha activity
8 months
- +1 more secondary outcomes
Study Arms (3)
fMRI Neurofeedback
EXPERIMENTALThe participants receive visual feedback (displayed on a screen) related to BOLD activity from their auditory cortices, and they are asked to learn to down-regulate it.
EEG Neurofeedback
EXPERIMENTALThe participants receive visual feedback (displayed on a screen) related to the ratio of alpha to delta localized activity from their auditory cortices, and they are asked to learn to up-regulate it.
Cognitive Behavioral Therapy
ACTIVE COMPARATORGroup therapy is provided by trained clinicians for research participants. Participants are confronted with tinnitus-inducting situations and trained to use diverse cognitive and behavioral coping skills to reduce the subjective impact of tinnitus burden. Such coping skills include relaxation, distraction, and de-catastrophizing, among other strategies.
Interventions
15 intervention sessions with a standard EEG-cap with 64 active electrodes.
10 intervention sessions of CBT group therapy, as per local university hospital standard of care.
Eligibility Criteria
You may qualify if:
- Age between 18 to 80 years
- Tinnitus Handicap Inventory ≥ 48
- Chronic, persistent, non-pulsatile tinnitus for minimum 6 months
- Functional hearing
- Normal inner ear structure assessment using an ear microscope, normal tympanic membrane mobility
- Participant willing, able and available to participate in the entire research, including completion of questionnaires and traveling to research sites for the duration of the trial
You may not qualify if:
- Contraindication to MRI (e.g. non compatible cochlear implant, pacemaker, deep brain stimulation)
- Conductive hearing loss exceeding 20 dB at two or more frequencies
- Known diagnoses causing tinnitus or hearing loss:
- Known systemic disease (vestibular schwannoma, endolymphatic hydrops)
- Lesion in central nervous system, including history of severe cranio-cerebral trauma
- Acute ear canal or middle ear inflammation or effusion
- Significant neurologic disease, psychiatric disease, substance abuse or acute allergic disease
- Ongoing medication that is known to treat, influence, or cause tinnitus (e.g. high-dose aspirin, quinidine, aminoglycosides)
- Ongoing or recent (completed since less than 4 weeks) tinnitus therapy (e.g. tinnitus maskers, acupuncture)
- Participation in competitive or pharmacological study
- Pregnant woman
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dept. of Otology, Audiology and Cochlear Implant Surgery, University Hospital Geneva
Geneva, Canton of Geneva, 1205, Switzerland
Related Publications (1)
Gninenko N, Trznadel S, Daskalou D, Gramatica L, Vanoy J, Voruz F, Robyn CL, Spadazzi A, Yulzari A, Sitaram R, Van De Ville D, Senn P, Haller S. Functional MRI Neurofeedback Outperforms Cognitive Behavioral Therapy for Reducing Tinnitus Distress: A Prospective Randomized Clinical Trial. Radiology. 2024 Feb;310(2):e231143. doi: 10.1148/radiol.231143.
PMID: 38349241DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pascal Senn, MD, PhD
Dept. of Otology, Audiology and Cochlear Implant Surgery, University Hospital Geneva
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 10, 2023
First Posted
February 21, 2023
Study Start
February 14, 2017
Primary Completion
December 6, 2022
Study Completion
March 30, 2023
Last Updated
November 14, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share